2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
To Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
To Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
Reports Strong First Quarter 2026 Financial Results
To Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
To Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
Q1
FY 2025
Q3
Q2
FY 2024
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Supplemental Filing
Amended Registration Statement for Securities of Certain Canadian Issuers
Appointment of Agent for Service of Process by Foreign Banks and Foreign Insurance Companies
Registration Statement for Securities of Certain Canadian Issuers